Last Updated: August 9, 2026

SYNALAR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Synalar, and when can generic versions of Synalar launch?

Synalar is a drug marketed by Eurofarma and is included in four NDAs.

The generic ingredient in SYNALAR is fluocinolone acetonide. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Synalar

A generic version of SYNALAR was approved as fluocinolone acetonide by FOUGERA PHARMS INC on December 16th, 1982.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SYNALAR?
  • What are the global sales for SYNALAR?
  • What is Average Wholesale Price for SYNALAR?
Summary for SYNALAR
Recent Clinical Trials for SYNALAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Noah Rosenberg, MDPhase 4
LEO PharmaPhase 1

See all SYNALAR clinical trials

Pharmacology for SYNALAR

US Patents and Regulatory Information for SYNALAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eurofarma SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-004 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eurofarma SYNALAR fluocinolone acetonide OINTMENT;TOPICAL 013960-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eurofarma SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-002 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eurofarma SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787-005 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Eurofarma SYNALAR-HP fluocinolone acetonide CREAM;TOPICAL 016161-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.